Little is known about the properties of GABA receptors in the amphibian brain. The GABA(A) receptor is widespread in the mammalian brain, and can be specifically labeled with the receptor agonist [3H]muscimol. The binding of [3H]muscimol to membrane preparations from the brain of the bullfrog, Rana catesbeiana, was investigated in kinetic, saturation, and inhibition experiments to determine whether this species possessed a GABA(A)-like receptor. Binding of 20 nM [3H]muscimol to membranes was specific and could be displaced by 1 mM GABA. Association binding curves showed that steady state occurred rapidly, within 2 min, and dissociation occurred within 5 min. The receptor was saturable with a single, high-affinity binding site (K(D)=19.2 nM; B(max)=1.8 pmol/mg protein). Binding of [3H]muscimol was inhibited in a dose-dependent fashion by muscimol, GABA, bicuculline methiodide, and bicuculline (in order of potency). Baclofen (at doses from 10(-9) to 10(-3) M) failed to displace [3H]muscimol. The binding characteristics and ligand specificity of [3H]muscimol binding sites in the bullfrog brain support the hypothesis that this amphibian possesses a GABA(A)-like receptor protein similar to the GABA(A) receptor characterized in mammals.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainres.2003.08.030DOI Listing

Publication Analysis

Top Keywords

gabaa receptor
12
[3h]muscimol binding
12
binding [3h]muscimol
12
bullfrog rana
8
rana catesbeiana
8
gabaa-like receptor
8
receptor
7
binding
7
[3h]muscimol
6
brain
5

Similar Publications

Gene Deficiency of δ Subunit-Containing GABA Receptor in mPFC Lead Learning and Memory Impairment in Mice.

Neurochem Res

January 2025

Laboratory of Chinese Medicine Brain Science, Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.

Maintaining GABAergic inhibition within physiological limits in the medial prefrontal cortex (mPFC) is critical for working memory. While synaptic GABAR typically mediate the primary component of mPFC inhibition, the role of extrasynaptic δ-GABAR in working memory remains unclear. To investigate this, we used fiber photometry to examine the effects of δ-GABAR in freely moving mice.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Background: Alzheimer's disease (AD) is characterized by the accumulation of amyloid-β (Aβ) plaques and tau tangles in the brain, and neurotransmission dysfunctions. Indeed, our group recently demonstrated that the γ-aminobutyric acid (GABA)ergic system is vulnerable to AD pathology in humans. However, whether this vulnerability is also present in AD rodent models is still unknown.

View Article and Find Full Text PDF

Aims: N-Demethylsinomenine (NDSM) demonstrates good analgesic efficacy in preclinical pain models. However, how NDSM exerts analgesic actions remains unknown.

Methods: We examined the analgesic effects of NDSM using both pain-evoked and pain-suppressed behavioral assays in two persistent pain models.

View Article and Find Full Text PDF

Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells.

PLoS One

January 2025

Department of Molecular Medicine, Brain Signalling Laboratory, Institute of Basic Medical Sciences, Section for Physiology, University of Oslo, Oslo, Norway.

Propofol and ketamine are widely used general anaesthetics, but have different effects on consciousness: propofol gives a deeply unconscious state, with little or no dream reports, whereas vivid dreams are often reported after ketamine anaesthesia. Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist, while propofol is a γ-aminobutyric-acid (GABAA) receptor positive allosteric modulator, but these mechanisms do not fully explain how these drugs alter consciousness. Most previous in vitro studies of cellular mechanisms of anaesthetics have used brain slices or neurons in a nearly "comatose" state, because no "arousing" neuromodulators were added.

View Article and Find Full Text PDF

Gastrointestinal dysfunction is a severe and common complication in diabetic patients. Some evidence shows that gamma-aminobutyric acid (GABA) and glutamate contribute to diabetic gastrointestinal abnormalities. Therefore, we examined the impact of prolonged treatment with insulin and magnesium supplements on the expression pattern of GABA type A (GABA-A), GABA-B, and N-methyl-D-aspartate (NMDA) glutamate receptors as well as nitric oxide synthase 1 (NOS-1) in the stomach of type 2 diabetic rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!